About this trial
This clinical trial compares efficacy in postoperative pain management in thoracic surgery between erector spinae block versus liposomal bupivacaine injections.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Video assisted pulmonary resection, pleurodesis or decortication
Disqualifiers
Allergy to local anesthetics
Patient undergoing bilateral surgery
Surgery is emergent as deemed by the principal investigator
Trial design
Parallel
Treatments tested in this trial
Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)
Drugpreoperative erector spinae block with bupivacaine (Marcaine®)
Intercostal nerve block
Drugintraoperative intercostal nerve block with liposomal bupivacaine (Exparel®)
Treatment groups
Trial outcomes
Primary outcomes
Postoperative pain control assessment
Study team will assess postoperative pain scores at 6, 12, 24 and 48 hours (Minimum numerical pain score of 0 and a maximum of 10)
Morphine equivalent assessment
Study team will collect information on all administered pain medications to calculate morphine equivalents
Secondary outcomes
Postoperative pain control assessment
Study team will assess postoperative pain scores at 72 hours (Minimum numerical pain score of 0 and a maximum of 10)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.